Here are five private equity forces driving growth in the ASC industry:
Author: Patsy Newitt
CMS is floating the implementation of a separate add-on payment for healthcare common procedure coding system code G2211 in its 2023 Medicare Physician Fee Schedule, according to an Oct. 13 report in JDSupra written by law firm Reed Smith.
Les Jebson, regional administrator at Greenville, S.C.-based Prisma Health, joined Becker's to discuss the threats to outpatient growth and what procedures are moving to the ASC setting.
Kenai, Alaska-based physician Ray Lynn Carlson, MD, and his clinics' managers have been indicted on 23 charges in a Medicare fraud case, Alaska Public Media reported Oct. 16.
Tom Cowhey, former CFO of Surgery Partners, has been appointed as interim CFO of CVS Health.
Gastroenterology has increasingly consolidated in the last five years, as private equity and management service organizations see the benefit in accessing economies of scale.
Procedures are continuing to move to the outpatient setting, which is driving ASC growth, but obstacles remain.
From cardiology to minimally invasive spine procedures, four ASC leaders joined Becker's to discuss which procedures they see moving to the outpatient setting.
The Tennessee Department of Health revoked the license of Delenya Allen, MD, alleging improper treatment of patients, CBS affiliate WREG reported Oct. 13.
Internal medicine physician Charles Adams, MD, and his Ringold, Ga.-based medical practice have been ordered to pay more than $27.5 million for submitting false claims to Medicare for chelation therapy reimbursements.
